Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
63
AUR Quote, Financials, Valuation and Earnings
Last price:
$6.69
Seasonality move
:
10.7%
Day range:
$7.01 - $7.55
52-week range:
$2.10 - $10.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
177.56x
P/B ratio:
6.92x
Volume:
11.5M
Avg. volume:
15.4M
1-year change:
181.51%
Market cap:
$13B
Revenue:
--
EPS (TTM):
-$0.47
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $82M | $68M | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -17.07% | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $179.4M | $697M | $677M | $716M | $676M | |
| Selling, General & Admin | $38.7M | $116M | $129M | $119M | $110M | |
| Other Inc / (Exp) | -$45K | -$29M | -$985M | $39M | $38M | |
| Operating Expenses | $218.1M | $813M | $806M | $835M | $786M | |
| Operating Income | -$218.1M | -$731M | -$738M | -$835M | -$786M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$214.4M | -$760M | -$1.7B | -$796M | -$748M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2K | -$5M | -- | -- | -- | |
| Net Income to Company | -$214.4M | -$755M | -$1.7B | -$796M | -$748M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$214.4M | -$755M | -$1.7B | -$796M | -$748M | |
| Basic EPS (Cont. Ops) | -$0.19 | -$1.22 | -$1.51 | -$0.60 | -$0.46 | |
| Diluted EPS (Cont. Ops) | -$0.19 | -$1.22 | -$1.51 | -$0.60 | -$0.46 | |
| Weighted Average Basic Share | $1.1B | $621M | $1.1B | $1.3B | $1.6B | |
| Weighted Average Diluted Share | $1.1B | $621M | $1.1B | $1.3B | $1.6B | |
| EBITDA | -$215M | -$715M | -$716M | -$814M | -$765M | |
| EBIT | -$218.1M | -$731M | -$738M | -$835M | -$786M | |
| Revenue (Reported) | -- | $82M | $68M | -- | -- | |
| Operating Income (Reported) | -$218.1M | -$731M | -$738M | -$835M | -$786M | |
| Operating Income (Adjusted) | -$218.1M | -$731M | -$738M | -$835M | -$786M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $26.4M | $2M | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -92.43% | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $219.9M | $169M | $170M | $171M | |
| Selling, General & Admin | -- | $35.8M | $31M | $28M | $28M | |
| Other Inc / (Exp) | -- | -$24.3M | -$96M | $6M | $6M | |
| Operating Expenses | -- | $255.7M | $200M | $198M | $199M | |
| Operating Income | -- | -$229.3M | -$198M | -$198M | -$199M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$253.6M | -$294M | -$192M | -$193M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$2.4M | -- | -- | -- | |
| Net Income to Company | -- | -$251.2M | -$294M | -$192M | -$193M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$251.2M | -$294M | -$192M | -$193M | |
| Basic EPS (Cont. Ops) | -- | -$0.22 | -$0.25 | -$0.12 | -$0.11 | |
| Diluted EPS (Cont. Ops) | -- | -$0.22 | -$0.25 | -$0.12 | -$0.11 | |
| Weighted Average Basic Share | -- | $1.1B | $1.2B | $1.5B | $1.7B | |
| Weighted Average Diluted Share | -- | $1.1B | $1.2B | $1.5B | $1.7B | |
| EBITDA | -- | -$224.2M | -$193M | -$192M | -$193M | |
| EBIT | -- | -$229.3M | -$198M | -$198M | -$199M | |
| Revenue (Reported) | -- | $26.4M | $2M | -- | -- | |
| Operating Income (Reported) | -- | -$229.3M | -$198M | -$198M | -$199M | |
| Operating Income (Adjusted) | -- | -$229.3M | -$198M | -$198M | -$199M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $68M | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $697M | $677M | $716M | $676M | |
| Selling, General & Admin | -- | $116M | $129M | $119M | $110M | |
| Other Inc / (Exp) | -- | -$29.6M | -$985M | $39M | $38M | |
| Operating Expenses | -- | $813M | $806M | $835M | $786M | |
| Operating Income | -- | -$731M | -$738M | -$835M | -$786M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$760M | -$1.7B | -$796M | -$748M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$5M | -- | -- | -- | |
| Net Income to Company | -- | -$755M | -$1.7B | -$796M | -$748M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$755M | -$1.7B | -$796M | -$748M | |
| Basic EPS (Cont. Ops) | -- | -$0.67 | -$1.51 | -$0.60 | -$0.47 | |
| Diluted EPS (Cont. Ops) | -- | -$0.67 | -$1.51 | -$0.60 | -$0.47 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -$715M | -$716M | -$814M | -$765M | |
| EBIT | -- | -$731M | -$738M | -$835M | -$786M | |
| Revenue (Reported) | -- | -- | $68M | -- | -- | |
| Operating Income (Reported) | -- | -$731M | -$738M | -$835M | -$786M | |
| Operating Income (Adjusted) | -- | -$731M | -$738M | -$835M | -$786M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $82M | $68M | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $697M | $677M | $716M | $676M | -- | |
| Selling, General & Admin | $116M | $129M | $119M | $110M | -- | |
| Other Inc / (Exp) | -$29.6M | -$985M | $39M | $38M | -- | |
| Operating Expenses | $813M | $806M | $835M | $786M | -- | |
| Operating Income | -$731M | -$738M | -$835M | -$786M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$760M | -$1.7B | -$796M | -$748M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$5M | -- | -- | -- | -- | |
| Net Income to Company | -$755M | -$1.7B | -$796M | -$748M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$755M | -$1.7B | -$796M | -$748M | -- | |
| Basic EPS (Cont. Ops) | -$0.67 | -$1.51 | -$0.60 | -$0.47 | -- | |
| Diluted EPS (Cont. Ops) | -$0.67 | -$1.51 | -$0.60 | -$0.47 | -- | |
| Weighted Average Basic Share | $4.5B | $4.6B | $5.3B | $6.5B | -- | |
| Weighted Average Diluted Share | $4.5B | $4.6B | $5.3B | $6.5B | -- | |
| EBITDA | -$715M | -$716M | -$814M | -$765M | -- | |
| EBIT | -$731M | -$738M | -$835M | -$786M | -- | |
| Revenue (Reported) | $82M | $68M | -- | -- | -- | |
| Operating Income (Reported) | -$731M | -$738M | -$835M | -$786M | -- | |
| Operating Income (Adjusted) | -$731M | -$738M | -$835M | -$786M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $387.3M | $1.6B | $262M | $501M | $211M | |
| Short Term Investments | -- | -- | $839M | $699M | $1B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $18.9M | -- | -- | -- | -- | |
| Other Current Assets | -- | $67M | $17M | $17M | $31M | |
| Total Current Assets | $406.4M | $1.7B | $1.1B | $1.2B | $1.3B | |
| Property Plant And Equipment | $101.8M | $245M | $229M | $216M | $224M | |
| Long-Term Investments | -- | -- | -- | $148M | -- | |
| Goodwill | $30M | $1.1B | -- | -- | -- | |
| Other Intangibles | $52.7M | $617M | $618M | $617M | -- | |
| Other Long-Term Assets | $12.3M | $37M | $36M | $37M | $43M | |
| Total Assets | $618.9M | $3.7B | $2B | $2.2B | $2.1B | |
| Accounts Payable | $6.5M | -- | -- | -- | -- | |
| Accrued Expenses | $3.4M | $28M | $70M | $31M | $28M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $6.7M | $12M | $13M | $15M | $16M | |
| Other Current Liabilities | $1.4M | -- | -- | -- | -- | |
| Total Current Liabilities | $32M | $91M | $83M | $111M | $105M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $895.5M | $348M | $217M | $250M | $263M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -$2M | $1M | $1M | |
| Common Equity | -$276.6M | $3.3B | $1.8B | $2B | $1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$276.6M | $3.3B | $1.8B | $2B | $1.9B | |
| Total Liabilities and Equity | $618.9M | $3.7B | $2B | $2.2B | $2.1B | |
| Cash and Short Terms | $387.3M | $1.6B | $1.1B | $1.2B | $1.2B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $1.6B | $262M | $501M | $211M | |
| Short Term Investments | -- | -- | $839M | $699M | $1B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $67M | $17M | $17M | $31M | |
| Total Current Assets | -- | $1.7B | $1.1B | $1.2B | $1.3B | |
| Property Plant And Equipment | -- | $245M | $229M | $216M | $224M | |
| Long-Term Investments | -- | -- | -- | $148M | -- | |
| Goodwill | -- | $1.1B | -- | -- | -- | |
| Other Intangibles | -- | $617M | $618M | $617M | -- | |
| Other Long-Term Assets | -- | $37M | $36M | $37M | $43M | |
| Total Assets | -- | $3.7B | $2B | $2.2B | $2.1B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | $28M | $70M | $31M | $28M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $12M | $13M | $15M | $16M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $91M | $83M | $111M | $105M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $348M | $217M | $250M | $263M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -$2M | $1M | $1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | $138K | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $3.3B | $1.8B | $2B | $1.9B | |
| Total Liabilities and Equity | -- | $3.7B | $2B | $2.2B | $2.1B | |
| Cash and Short Terms | -- | $1.6B | $1.1B | $1.2B | $1.2B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$214.4M | -$755M | -$1.7B | -$796M | -$748M | |
| Depreciation & Amoritzation | $3.1M | $16M | $22M | $21M | $21M | |
| Stock-Based Compensation | $16.9M | $220M | $156M | $160M | $144M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$191.9M | -$564M | -$508M | -$598M | -$611M | |
| Capital Expenditures | $6.7M | $48M | $15M | -- | -- | |
| Cash Acquisitions | -- | $294M | -- | -- | -- | |
| Cash From Investing | $343.3M | $250M | -$852M | $8M | -$172M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$532K | -- | -- | -- | -- | |
| Other Financing Activities | -- | $1.1B | -$2M | -$9M | -$5M | |
| Cash From Financing | $1.4M | $1.5B | $11M | $831M | $492M | |
| Beginning Cash (CF) | $247M | $400M | $1.6B | $277M | $518M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $152.9M | $1.2B | -$1.3B | $241M | -$291M | |
| Ending Cash (CF) | $399.8M | $1.6B | $277M | $518M | $227M | |
| Levered Free Cash Flow | -$198.6M | -$612M | -$523M | -$613M | -$645M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$251.2M | -$294M | -$192M | -$193M | |
| Depreciation & Amoritzation | -- | $5.2M | $5M | $6M | $6M | |
| Stock-Based Compensation | -- | $101.6M | $44M | $37M | $35M | |
| Change in Accounts Receivable | -- | $5.6M | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$143.1M | -$141M | -$133M | -$142M | |
| Capital Expenditures | -- | $15.9M | $3M | -- | -- | |
| Cash Acquisitions | -- | -$439K | -- | -- | -- | |
| Cash From Investing | -- | -$12.3M | -$86M | -$324M | $73M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$1M | -$2M | |
| Cash From Financing | -- | $1.1B | $1M | $4M | $17M | |
| Beginning Cash (CF) | -- | $643.9M | $503M | $971M | $279M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $982M | -$226M | -$453M | -$52M | |
| Ending Cash (CF) | -- | $1.6B | $277M | $518M | $227M | |
| Levered Free Cash Flow | -- | -$159M | -$144M | -$137M | -$150M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$755M | -$1.7B | -$796M | -$748M | |
| Depreciation & Amoritzation | -- | $16M | $22M | $21M | $21M | |
| Stock-Based Compensation | -- | $220M | $156M | $160M | $144M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$564M | -$508M | -$598M | -$611M | |
| Capital Expenditures | -- | $34.9M | $15M | -- | -- | |
| Cash Acquisitions | -- | $294M | -- | -- | -- | |
| Cash From Investing | -- | $250M | -$852M | $8M | -$172M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$9M | -$5M | |
| Cash From Financing | -- | $1.5B | $11M | $831M | $492M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $1.2B | -$1.3B | $241M | -$291M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$612M | -$523M | -$613M | -$645M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$755M | -$1.7B | -$796M | -$748M | -- | |
| Depreciation & Amoritzation | $16M | $22M | $21M | $21M | -- | |
| Stock-Based Compensation | $220M | $156M | $160M | $144M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$564M | -$508M | -$598M | -$611M | -- | |
| Capital Expenditures | $34.9M | $15M | -- | -- | -- | |
| Cash Acquisitions | $294M | -- | -- | -- | -- | |
| Cash From Investing | $250M | -$852M | $8M | -$172M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$2M | -$9M | -$5M | -- | |
| Cash From Financing | $1.5B | $11M | $831M | $492M | -- | |
| Beginning Cash (CF) | $2.8B | $3.2B | $1.6B | $1.7B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.2B | -$1.3B | $241M | -$291M | -- | |
| Ending Cash (CF) | $4B | $1.9B | $1.9B | $1.4B | -- | |
| Levered Free Cash Flow | -$612M | -$523M | -$613M | -$645M | -- | |
Get AUR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AUR
Sector
P/E ratio
--
23.00x
PEG ratio
--
0.02x
P/B ratio
6.92x
2.21x
Price / LTM sales
177.56x
1.57x
Growth Metrics
AUR
Sector
Revenue growth
--
5.13%
Earnings growth
--
12.31%
Revenue (5-year growth)
--
6.64%
Earnings forecast
-$0.12
$0.14
Profitability
AUR
Sector
Profitability FY 2024
--
$92.8M
Return on invested capital
--
0.98%
Return on assets
--
0.23%
Return on equity
--
2.05%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
May
8
Estimated Next Earnings Date
May
14
Balance Sheet
AUR
Sector
Total cash
$1.2B
$56.7M
Short term investments
$1B
$20.9M
Total assets
$2.1B
$264.2M
Long term debt
--
$7.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
